+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
MALE
ID05800665

Phase 1 Study of RO7656594 Evaluating Safety and Activity in Advanced or Metastatic Prostate Cancer with Dose Escalation and Expansion

Led by Genentech, Inc. · Updated on 2026-11-03

210

Participants Needed

26

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, pharmacokinetics, and early activity of RO7656594 in adult male participants with advanced or metastatic prostate cancer. This phase 1 study aims to find recommended doses and regimens for RO7656594 for future studies. Participants have advanced prostate adenocarcinoma without small-cell or neuroendocrine features and have undergone prior therapies including androgen receptor-targeted agents and taxane chemotherapy or are ineligiblerefuse taxane treatment. Participants receive RO7656594 orally at specified doses on certain days within each 28-day cycle. The study includes a dose escalation phase where doses increase in successive groups until a threshold is reached, followed by an expansion phase where participants receive doses at or below the maximum tolerated or administered dose. Treatment continues with monitoring for adverse events and dose-limiting toxicities. During the study, participants are monitored for side effects and drug levels in the blood over up to 24 months from the first dose. Researchers measure adverse events, dose-limiting toxicities during the first cycle, and prostate-specific antigen PSA response rates. Participants undergo regular assessments including safety evaluations and pharmacokinetic sampling. The total study duration may last up to approximately two years after the final dose.

CONDITIONS

Brief Title

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Research Team

G

GO44537 https://forpatients.roche.com/ No attachments to email below.

F

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here